Nevro (NVRO) Gross Profit Margin starting from the fourth quarter 2024 to fourth quarter 2023, Profitability Trends and Ranking, Fundamental Ratios - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Gross Margin
• EBITDA Margin
• Operating Margin
• Net Margin
• Pre-Tax Margin
• Effective Tax Rate
• Free Cash Flow Margin
• Cash Flow Margin
Nevro Corp   (NYSE: NVRO)


Nevro 's Gross Profit Margin by quarter

Trends, Rankings, Statistics


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

NVRO Gross Profit Margin (Dec 31 2024)
Q4 		(Sep 30 2024)
Q3 		(Jun 30 2024)
Q2 		(Mar 31 2024)
Q1 		(Dec 31 2023)
Q4
Y / Y Revenue Change -9.01 %
Seq. Revenue Change 9.63 %
Revenue In Millions $105.92
Gross Profit Margin 62.24 %
Gross Profit Margin Total Ranking # 1392
Gross Profit In Millions $65.92
Y / Y Gross Profit Change -19.09 %
Seq. Gross Profit Change 2.02 %


Commenting fourth quarter 2024 Gross Profit Margin
Nevro has managed to improve its Revenue sequentially to $105.92 millions by 9.63 % faster than Gross Profit increase of 2.02 % to $65.92 millions, this led to contraction in Gross Profit Margin to 62.24 %, below company average.


Observing fourth quarter 2024 results within Medical Equipment & Supplies industry 82 other companies have achieved higher Gross Profit Margin. While Gross Profit Margin overall ranking has deteriorated relative to the three months before, from 1175 to 1392.
Learn about Gross Margin
NVRO's Gross Profit Margin fourth quarter 2024 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 83
Healthcare Sector # 252
Overall # 1378

Gross Profit Margin Statistics
High Average Low
71.11 % 67.38 % 51.76 %
(Dec 31 2020)   (Jun 30 2015)


NVRO Gross Income Trends • More of NVRO's Profitabilty Ratios • NVRO Stock Quotes and Charts


Other Gross Profit Margin Profitability Ratios
NVRO's Cumulative Gross Profit Margin
Medical Equipment & Supplies Industry Gross Profit Margin Trends and Statistics
Healthcare Sector Gross Profit Margin Statistics
Gross Profit Margin Profitability Trends for overall market
NVRO's Gross Profit Margin Profitability versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Gross Profit Margin
Lowest Ranking Gross Profit Margin
Gross Profit Margin Profit Margin for NVRO's Competitors
Gross Profit Margin Profit Margin for Nevro 's Suppliers
Gross Profit Margin Profit Margin for NVRO's Customers

You may also want to know
NVRO's Annual Growth Rates NVRO's Profitability Ratios NVRO's Asset Turnover Ratio NVRO's Dividend Growth
NVRO's Roe NVRO's Valuation Ratios NVRO's Financial Strength Ratios NVRO's Gross Profit Growth
NVRO's Roa NVRO's Inventory Turnover Ratio NVRO's Growth Rates NVRO's Dividend Comparisons


Companies with similar Gross Profit Margin in the quarter ending Dec 31 2024, within Medical Equipment & Supplies Industry Gross Profit MarginDec 31 2024 MRQ Gross ProfitDec 31 2024 MRQ Revenue
Edwards Lifesciences Corporation  99.21 %$ 1,093.600  Millions$ 1,102.300  Millions
Longduoduo Co Ltd  98.38 %$ 1.747  Millions$ 1.776  Millions
Electrocore Inc   95.67 %$ 6.052  Millions$ 6.326  Millions
Catheter Precision Inc   92.62 %$ 0.138  Millions$ 0.149  Millions
Semler Scientific inc   91.13 %$ 11.313  Millions$ 12.414  Millions
Petvivo Holdings Inc   89.46 %$ 0.522  Millions$ 0.583  Millions
Baird Medical Investment Holdings Limited  89.09 %$ 32.654  Millions$ 36.654  Millions
Avita Medical Inc   87.61 %$ 16.126  Millions$ 18.406  Millions
Ceribell Inc   87.61 %$ 16.238  Millions$ 18.534  Millions
Vycor Medical Inc   87.29 %$ 0.397  Millions$ 0.455  Millions
Trisalus Life Sciences Inc   86.31 %$ 7.045  Millions$ 8.162  Millions
Sanara Medtech Inc   85.74 %$ 24.056  Millions$ 28.056  Millions
Neuraxis Inc   84.71 %$ 0.645  Millions$ 0.761  Millions
Sight Sciences Inc   84.66 %$ 16.561  Millions$ 19.561  Millions
Inspire Medical Systems inc   84.63 %$ 203.730  Millions$ 240.730  Millions
Venus Concept Inc   84.48 %$ 10.889  Millions$ 12.889  Millions
Delcath Systems Inc   83.42 %$ 12.974  Millions$ 15.552  Millions
Icad Inc  83.36 %$ 3.697  Millions$ 4.435  Millions
Milestone Scientific Inc   83.11 %$ 1.511  Millions$ 1.818  Millions
Mimedx Group Inc   81.80 %$ 75.997  Millions$ 92.906  Millions
Fonar Corporation  81.47 %$ 20.327  Millions$ 24.950  Millions
Treace Medical Concepts Inc   80.74 %$ 55.477  Millions$ 68.708  Millions
Inmode Ltd   80.31 %$ 317.066  Millions$ 394.818  Millions
Novocure Limited  79.25 %$ 127.800  Millions$ 161.266  Millions
Nuo Therapeutics Inc   78.12 %$ 0.308  Millions$ 0.395  Millions
Si bone inc   77.90 %$ 38.777  Millions$ 49.777  Millions
Sanuwave Health Inc   77.87 %$ 8.041  Millions$ 10.326  Millions
Electromed Inc   77.68 %$ 12.627  Millions$ 16.255  Millions
Orchestra Biomed Holdings Inc   77.08 %$ 0.195  Millions$ 0.253  Millions
Zynex inc   76.95 %$ 35.418  Millions$ 46.025  Millions




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.